Breaking News Instant updates and real-time market news.

ROKU

Roku

$165.76 /

-0.57 (-0.34%)

09:19
08/06/20
08/06
09:19
08/06/20
09:19

Roku price target raised to $185 from $140 at Oppenheimer

Oppenheimer analyst Jason Helfstein raised the firm's price target on Roku to $185 from $140 as Q2 results topped Street expectations on better than anticipated Platform results and comp valuations have expanded. The analyst keeps an Outperform rating on the shares.

  • 24

    Aug

  • 02

    Sep

  • 17

    Mar

ROKU Roku
$165.76 /

-0.57 (-0.34%)

08/06/20 Rosenblatt
Rosenblatt ups Roku price target to $195, says buy on weakness after earnings
08/06/20 Susquehanna
Roku price target raised to $185 from $145 at Susquehanna
08/06/20 Needham
Roku price target raised to $190 from $150 at Needham
08/06/20 Wedbush
Roku price target raised to $160 from $136 at Wedbush

TODAY'S FREE FLY STORIES

Conference/Events
Ambu management to meet virtually with JPMorgan » 04:55
09/26/20
09/26
04:55
09/26/20
04:55
AMBBY

Ambu

$0.00 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on September 28-30 hosted by JPMorgan.

ShowHide Related Items >><<
AMBBY Ambu
$0.00 /

+ (+0.00%)

08/28/20 JPMorgan
Ambu price target lowered to DKK 190 from DKK 219 at JPMorgan
08/27/20 SEB Equities
Ambu upgraded to Buy from Hold at SEB Equities
05/06/20 JPMorgan
Ambu downgraded to Neutral from Overweight at JPMorgan
05/06/20 Danske Bank
Ambu upgraded to Hold from Sell at Danske Bank
Hot Stocks
Lockheed Martin announces additional $1.3B share repurchase program » 18:35
09/25/20
09/25
18:35
09/25/20
18:35
LMT

Lockheed Martin

$386.86 /

+8.07 (+2.13%)

Lockheed Martin's…

Lockheed Martin's board has authorized the purchase of up to an additional $1.3B of Lockheed Martin common stock under its share repurchase program. With this increase, total authorization for future repurchases under the share repurchase program is approximately $3B.

ShowHide Related Items >><<
LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/08/20 Morgan Stanley
Lockheed Martin initiated with an Overweight at Morgan Stanley
07/24/20 Argus
Lockheed Martin price target raised to $450 from $425 at Argus
07/17/20 RBC Capital
Lockheed Martin price target lowered to $404 from $410 at RBC Capital
LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

Hot Stocks
Lockheed Martin raises quarterly dividend to $2.60 from $2.40 per share » 18:34
09/25/20
09/25
18:34
09/25/20
18:34
LMT

Lockheed Martin

$386.86 /

+8.07 (+2.13%)

The dividend is payable…

The dividend is payable on Dec. 24 to holders of record as of the close of business on Dec. 1.

ShowHide Related Items >><<
LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/08/20 Morgan Stanley
Lockheed Martin initiated with an Overweight at Morgan Stanley
07/24/20 Argus
Lockheed Martin price target raised to $450 from $425 at Argus
07/17/20 RBC Capital
Lockheed Martin price target lowered to $404 from $410 at RBC Capital
LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

LMT Lockheed Martin
$386.86 /

+8.07 (+2.13%)

Hot Stocks
Brunswick CEO: Sales up significantly since last year » 18:23
09/25/20
09/25
18:23
09/25/20
18:23
BC

Brunswick

$58.81 /

+0.23 (+0.39%)

In an interview on…

In an interview on CNBC's Mad Money, David Foulkes said Brunswick has hired more than 1,000 people over the past few months to keep up with production. According to Foulkes, this season has really expanded and sales are up significantly since last year with rising production. More women than ever are registering for boats and the average age of the boat buyer has dropped, he said. "Our cash generation has been strong and the stock has plenty of room to run," Foulkes noted. "People are entering in all areas of the portfolio."

ShowHide Related Items >><<
BC Brunswick
$58.81 /

+0.23 (+0.39%)

BC Brunswick
$58.81 /

+0.23 (+0.39%)

09/15/20
Fly Intel: Top five analyst initiations
09/15/20 Citi
Brunswick initiated with a Neutral at Citi
07/07/20 KeyBanc
Brunswick price target raised to $72 from $67 at KeyBanc
07/06/20 CL King
Brunswick price target raised to $79 from $52 at CL King
BC Brunswick
$58.81 /

+0.23 (+0.39%)

BC Brunswick
$58.81 /

+0.23 (+0.39%)

Hot Stocks
Pretium Resources CFO Yip to step down » 18:01
09/25/20
09/25
18:01
09/25/20
18:01
PVG

Pretium Resources

$12.60 /

-0.03 (-0.24%)

Pretium Resources…

Pretium Resources announced that Tom S.Q. Yip, Executive Vice President and Chief Financial Officer, will step down from his role as Chief Financial Officer of the company on September 30, 2020. Yip will continue to serve as Executive Vice President and assist with an orderly transition until October 30, 2020. Matthew Quinlan, Vice President, Finance, will succeed Yip as Chief Financial Officer of the company effective September 30, 2020. Additionally, Pretivm announces that Kenneth C. McNaughton, Vice President and Chief Exploration Officer, has informed the company that he will be retiring effective September 30, 2020.

ShowHide Related Items >><<
PVG Pretium Resources
$12.60 /

-0.03 (-0.24%)

PVG Pretium Resources
$12.60 /

-0.03 (-0.24%)

09/16/20 CIBC
Pretium Resources price target raised to C$23 from C$13 at CIBC
08/07/20 BMO Capital
Pretium Resources price target raised to C$18.50 from C$15 at BMO Capital
07/20/20 Scotiabank
Pretium Resources price target raised to C$12 from C$11 at Scotiabank
05/04/20 BMO Capital
Pretium Resources price target raised to C$13 from C$12 at BMO Capital
PVG Pretium Resources
$12.60 /

-0.03 (-0.24%)

PVG Pretium Resources
$12.60 /

-0.03 (-0.24%)

Hot Stocks
Aquestive Therapeutics gets FDA CRL for Libervant in seizure cluster management » 17:41
09/25/20
09/25
17:41
09/25/20
17:41
AQST

Aquestive Therapeutics

$7.59 /

-0.2 (-2.57%)

The company states:…

The company states: "Aquestive Therapeutics announced that the FDA has issued a complete response letter, or CRL, regarding the New Drug Application for Libervant, or diazepam, Buccal Film for management of seizure clusters. The FDA issues a CRL to indicate that the review cycle for an application is complete but the application cannot be approved in its current form. In the CRL, the FDA cited that, in a study submitted by the company with the NDA, certain weight groups showed a lower drug exposure level than desired. The company intends to provide to the FDA additional information on PK modeling to demonstrate that dose adjustments will obtain the desired exposure levels. There were no other safety, clinical pharmacology/biopharmaceutics or CMC issues identified in the CRL. The FDA did cite a small number of protocol deviations in blood draws in one of the studies in the NDA. The company believes, based on discussions with the FDA, that the company will not need to conduct any further clinical studies in order to cure the items cited in the CRL, and will confirm that view in its upcoming follow-up meeting with the FDA. Based on interactions with the Agency, the company believes that this CRL will not be a barrier to ultimate approval, as the CRL was limited to providing additional information on PK modeling for an adjusted dosing regimen for a limited subset of patient weight categories. The company plans to request a Type A meeting with the FDA in the coming weeks and to resubmit the NDA prior to the end of 2020 with the adjusted dosage regimen for the identified weight groups at issue. A submission before the end of the year should result in a PDUFA Action Date in the 1st half of 2021. The Agency did not include any indication regarding approval of U.S. market access for Libervant at this time."

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$7.59 /

-0.2 (-2.57%)

AQST Aquestive Therapeutics
$7.59 /

-0.2 (-2.57%)

09/24/20 Lake Street
Lake Street says FDA decision on Aquestive's Libervant may come Friday or Monday
05/22/20 H.C. Wainwright
Aquestive Therapeutics price target raised to $15 from $13 at H.C. Wainwright
03/16/20 Wedbush
Aquestive Therapeutics price target lowered to $31 from $36 at Wedbush
02/10/20 Wedbush
Wedbush delays launch estimates for Libervant, ups Aquestive Therapeutics target
AQST Aquestive Therapeutics
$7.59 /

-0.2 (-2.57%)

  • 13
    Dec
AQST Aquestive Therapeutics
$7.59 /

-0.2 (-2.57%)

Hot Stocks
Delta sees $2B-$2.5B pretax charge from Boeing aircraft retirement » 17:32
09/25/20
09/25
17:32
09/25/20
17:32
DAL

Delta Air Lines

$29.78 /

+0.77 (+2.65%)

, BA

Boeing

$156.07 /

+10.08 (+6.90%)

In a regulatory filing,…

In a regulatory filing, Delta (DAL) said it has decided to retire the company's Boeing (BA) 717-200 aircraft and the remainder of its 767-300ER aircraft by December 2025 and its CRJ-200 aircraft by December 2023, earlier than previously scheduled. These plans are another step in Delta's fleet simplification strategy, which is intended to streamline and modernize Delta's fleet, enhance the customer experience, and generate cost savings. As a result of this determination, Delta evaluated its Boeing 717-200 and CRJ-200 aircraft as well as the remainder of its Boeing 767-300ER aircraft for impairment and, on September 23, 2020, concluded that the carrying value of these aircraft was no longer recoverable when compared to their estimated remaining future cash flows. Consequently, during the September 2020 quarter, Delta expects to record non-cash impairment charges associated with these aircraft. Although the actual amount of the charges has not yet been finalized, Delta expects the aggregate impairment and other related charges to be in a range from $2B-$2.5B, before tax. An immaterial amount associated with the charges is expected to result in future cash expenditures. Delta may continue to consider further opportunities for early aircraft retirements in an effort to modernize and simplify its fleet.

ShowHide Related Items >><<
DAL Delta Air Lines
$29.78 /

+0.77 (+2.65%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

DAL Delta Air Lines
$29.78 /

+0.77 (+2.65%)

09/18/20 Barclays
Delta Air Lines price target raised to $30 from $26 at Barclays
09/15/20 Seaport Global
Delta Air Lines initiated with a Buy at Seaport Global
09/08/20 Morgan Stanley
Delta Air Lines initiated with an Overweight at Morgan Stanley
09/02/20
Fly Intel: Top five analyst downgrades
BA Boeing
$156.07 /

+10.08 (+6.90%)

09/24/20 Wolfe Research
Boeing upgraded to Peer Perform from Underperform at Wolfe Research
09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/20/20 Goldman Sachs
Boeing upgraded to Conviction Buy from Buy at Goldman Sachs
09/10/20 Susquehanna
Boeing 737 MAX making progress, but estimates lowered at Susquehanna
DAL Delta Air Lines
$29.78 /

+0.77 (+2.65%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

DAL Delta Air Lines
$29.78 /

+0.77 (+2.65%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

DAL Delta Air Lines
$29.78 /

+0.77 (+2.65%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

DAL Delta Air Lines
$29.78 /

+0.77 (+2.65%)

BA Boeing
$156.07 /

+10.08 (+6.90%)

Hot Stocks
Artesian Resources raises quarterly dividend by 3% to 25.71c per share » 17:25
09/25/20
09/25
17:25
09/25/20
17:25
ARTNA

Artesian Resources

$33.57 /

+0.47 (+1.42%)

The dividend is payable…

The dividend is payable November 20, 2020 to shareholders of record at the close of business on November 9, 2020.

ShowHide Related Items >><<
ARTNA Artesian Resources
$33.57 /

+0.47 (+1.42%)

ARTNA Artesian Resources
$33.57 /

+0.47 (+1.42%)

03/16/20 Boenning & Scattergood
Artesian Resources initiated with an Outperform at Boenning & Scattergood
Hot Stocks
Raytheon Technologies awarded $212.76M Missile Defense Agency contract » 17:23
09/25/20
09/25
17:23
09/25/20
17:23
RTX

Raytheon Technologies

$57.49 /

+0.1 (+0.17%)

Raytheon Technologies was…

Raytheon Technologies was awarded a sole-source contract in the amount of $212.76M under a Foreign Military Sale, or FMS, case to the United Arab Emirates, or UAE. The contract type will be a hybrid firm-fixed-price, cost-plus-incentive-fee, cost-plus-fixed-fee and cost-reimbursement contract. The contractor will provide one prime power unit and five years of sustainment services for two terminal high altitude area defense Army/Navy transportable radar surveillance and control-series 2, or AN/TPY-2, radars for this contract. The work will be performed in Woburn, Massachusetts, and some support services will be provided in-country. The performance period is October 1 through September 30, 2025. UAE FMS funds in the amount of $212.76M will be used to fund this effort. The Missile Defense Agency is the contracting activity.

ShowHide Related Items >><<
RTX Raytheon Technologies
$57.49 /

+0.1 (+0.17%)

RTX Raytheon Technologies
$57.49 /

+0.1 (+0.17%)

09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/20/20 Goldman Sachs
Raytheon upgraded to Conviction Buy from Buy at Goldman Sachs
09/08/20 Morgan Stanley
Raytheon Technologies initiated with an Overweight at Morgan Stanley
07/29/20 Argus
Raytheon Technologies downgraded to Hold from Buy at Argus
RTX Raytheon Technologies
$57.49 /

+0.1 (+0.17%)

RTX Raytheon Technologies
$57.49 /

+0.1 (+0.17%)

RTX Raytheon Technologies
$57.49 /

+0.1 (+0.17%)

RTX Raytheon Technologies
$57.49 /

+0.1 (+0.17%)

Conference/Events
Incyte and MorphoSys to hold a joint conference call » 17:17
09/25/20
09/25
17:17
09/25/20
17:17
MOR

MorphoSys

$31.41 /

+0.7 (+2.28%)

, INCY

Incyte

$86.48 /

+1.38 (+1.62%)

Incyte and MorphoSys hold…

Incyte and MorphoSys hold a joint conference call to discuss the unmet need and global opportunities for Tafasitamab in Non-Hodgkin Lymphomas on September 29 at 9 am. Webcast Link

ShowHide Related Items >><<
MOR MorphoSys
$31.41 /

+0.7 (+2.28%)

INCY Incyte
$86.48 /

+1.38 (+1.62%)

MOR MorphoSys
$31.41 /

+0.7 (+2.28%)

08/10/20 Citi
MorphoSys initiated with a Buy at Citi
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
06/25/20 RBC Capital
MorphoSys downgraded to Sector Perform from Outperform at RBC Capital
INCY Incyte
$86.48 /

+1.38 (+1.62%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
INCY Incyte
$86.48 /

+1.38 (+1.62%)

MOR MorphoSys
$31.41 /

+0.7 (+2.28%)

INCY Incyte
$86.48 /

+1.38 (+1.62%)

INCY Incyte
$86.48 /

+1.38 (+1.62%)

Hot Stocks
Chesapeake Utilities to replace Momenta in S&P 600 at open on 10/1 » 17:17
09/25/20
09/25
17:17
09/25/20
17:17
CPK

Chesapeake Utilities

$76.42 /

+0.84 (+1.11%)

, MNTA

Momenta

$52.39 /

-0.02 (-0.04%)

, JNJ

Johnson & Johnson

$145.71 /

+0.97 (+0.67%)

Johnson & Johnson…

Johnson & Johnson (JNJ) is acquiring Momenta Pharmaceuticals (MNTA) in a deal expected to be completed soon pending final conditions.

ShowHide Related Items >><<
MNTA Momenta
$52.39 /

-0.02 (-0.04%)

JNJ Johnson & Johnson
$145.71 /

+0.97 (+0.67%)

CPK Chesapeake Utilities
$76.42 /

+0.84 (+1.11%)

CPK Chesapeake Utilities
$76.42 /

+0.84 (+1.11%)

01/08/20 Guggenheim
Guggenheim changes eight ratings, names Exelon best idea in 2020 Utility outlook
01/07/20 Guggenheim
Chesapeake Utilities initiated with a Neutral at Guggenheim
12/20/19 Janney Montgomery Scott
Chesapeake Utilities upgraded to Buy from Neutral at Janney Montgomery Scott
10/24/19 Sidoti
Chesapeake Utilities initiated with a Buy at Sidoti
MNTA Momenta
$52.39 /

-0.02 (-0.04%)

08/25/20 Baird
Immunovant price target raised to $47 from $31 at Baird
08/25/20 Chardan
Immunovant price target raised to $45 from $35 at Chardan
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
JNJ Johnson & Johnson
$145.71 /

+0.97 (+0.67%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
MNTA Momenta
$52.39 /

-0.02 (-0.04%)

JNJ Johnson & Johnson
$145.71 /

+0.97 (+0.67%)

CPK Chesapeake Utilities
$76.42 /

+0.84 (+1.11%)

  • 12
    Dec
JNJ Johnson & Johnson
$145.71 /

+0.97 (+0.67%)

MNTA Momenta
$52.39 /

-0.02 (-0.04%)

JNJ Johnson & Johnson
$145.71 /

+0.97 (+0.67%)

MNTA Momenta
$52.39 /

-0.02 (-0.04%)

JNJ Johnson & Johnson
$145.71 /

+0.97 (+0.67%)

Hot Stocks
Toll Brothers CFO sells 10K shares of common stock » 17:15
09/25/20
09/25
17:15
09/25/20
17:15
TOL

Toll Brothers

$47.90 /

+0.42 (+0.88%)

In a regulatory filing,…

In a regulatory filing, Toll Brothers disclosed that its CFO Martin Connor sold 10K shares of common stock on September 25th in a total transaction size of $480K. The holding represents about 17% of his total owned.

ShowHide Related Items >><<
TOL Toll Brothers
$47.90 /

+0.42 (+0.88%)

TOL Toll Brothers
$47.90 /

+0.42 (+0.88%)

09/22/20 Barclays
Toll Brothers price target raised to $45 from $43 at Barclays
08/27/20 BTIG
Toll Brothers price target raised to $36 from $27 at BTIG
08/27/20 Barclays
Toll Brothers price target raised to $43 from $29 at Barclays
08/26/20 Wedbush
Toll Brothers price target raised to $53 from $45 at Wedbush
TOL Toll Brothers
$47.90 /

+0.42 (+0.88%)

TOL Toll Brothers
$47.90 /

+0.42 (+0.88%)

TOL Toll Brothers
$47.90 /

+0.42 (+0.88%)

TOL Toll Brothers
$47.90 /

+0.42 (+0.88%)

Hot Stocks
Datadog CFO sells 35K shares of common stock » 17:13
09/25/20
09/25
17:13
09/25/20
17:13
DDOG

Datadog

$90.50 /

+2.13 (+2.41%)

In a regulatory filing,…

In a regulatory filing, Datadog disclosed that its CFO David Obstler sold 35K shares of common stock on September 23rd in a total transaction size of $3.25M. The holding represents about 8% of his total owned.

ShowHide Related Items >><<
DDOG Datadog
$90.50 /

+2.13 (+2.41%)

DDOG Datadog
$90.50 /

+2.13 (+2.41%)

09/25/20 Baird
Baird starts Datadog at Neutral, citing 'premium valuation'
09/24/20 Baird
Datadog initiated with a Neutral at Baird
09/21/20
Snowflake initiated with a Sell at Summit Insights
09/16/20
Fly Intel: Top five analyst initiations
DDOG Datadog
$90.50 /

+2.13 (+2.41%)

DDOG Datadog
$90.50 /

+2.13 (+2.41%)

DDOG Datadog
$90.50 /

+2.13 (+2.41%)

DDOG Datadog
$90.50 /

+2.13 (+2.41%)

Periodicals
Windows XP, Server 2003 source codes leaked online, Verge reports » 17:12
09/25/20
09/25
17:12
09/25/20
17:12
MSFT

Microsoft

$207.75 /

+4.66 (+2.29%)

Microsoft's source…

Microsoft's source code for Windows XP and Windows Server 2003 has been leaked, as torrent files for both source codes have been published on a number of file sharing sites this week, The Verge's Tom Warren reports. The occurrence marks the first time source code for XP has leaked publicly, Warren notes. The Verge has verified that the source code leak is legitimate, and a Microsoft spokesperson told the Verge that the company is "investigating the matter." Reference Link

ShowHide Related Items >><<
MSFT Microsoft
$207.75 /

+4.66 (+2.29%)

MSFT Microsoft
$207.75 /

+4.66 (+2.29%)

09/24/20 Lynx
Microsoft's Bethesda deal positive for AMD, says Lynx
09/24/20 Jefferies
Jefferies 'overwhelmed' by announcements and innovation at Microsoft Ignite
09/23/20 Colliers
Harmonic opportunity in focus after SES partners with Microsoft, says Colliers
09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
MSFT Microsoft
$207.75 /

+4.66 (+2.29%)

MSFT Microsoft
$207.75 /

+4.66 (+2.29%)

MSFT Microsoft
$207.75 /

+4.66 (+2.29%)

MSFT Microsoft
$207.75 /

+4.66 (+2.29%)

MSFT Microsoft
$207.75 /

+4.66 (+2.29%)

Periodicals
American Airlines gets loan facility up to $5.48B, Bloomberg reports » 17:12
09/25/20
09/25
17:12
09/25/20
17:12
AAL

American Airlines

$12.28 /

+0.51 (+4.33%)

The facility may be…

The facility may be increased to $7.5B, Bloomberg noted.

ShowHide Related Items >><<
AAL American Airlines
$12.28 /

+0.51 (+4.33%)

AAL American Airlines
$12.28 /

+0.51 (+4.33%)

09/02/20
Fly Intel: Top five analyst downgrades
09/02/20 Berenberg
Berenberg ups Southwest to Buy, cuts American to Sell amid airline rating shift
09/02/20 Berenberg
American Airlines downgraded to Sell from Hold at Berenberg
07/28/20 Citi
Citi cuts American Airlines target to $11, opens negative catalyst watch
AAL American Airlines
$12.28 /

+0.51 (+4.33%)

  • 23
    Jun
AAL American Airlines
$12.28 /

+0.51 (+4.33%)

AAL American Airlines
$12.28 /

+0.51 (+4.33%)

AAL American Airlines
$12.28 /

+0.51 (+4.33%)

Syndicate
CNS Pharmaceuticals files to sell 2.1M shares of common stock for holders  17:02
09/25/20
09/25
17:02
09/25/20
17:02
CNSP

CNS Pharmaceuticals

$1.88 /

+0.14 (+8.05%)

 
ShowHide Related Items >><<
CNSP CNS Pharmaceuticals
$1.88 /

+0.14 (+8.05%)

CNSP CNS Pharmaceuticals
$1.88 /

+0.14 (+8.05%)

08/24/20 Ladenburg
CNS Pharmaceuticals initiated with a Buy at Ladenburg
12/04/19 Benchmark
CNS Pharmaceuticals initiated with a Speculative Buy at Benchmark
  • 08
    Nov
Periodicals
Google CEO says company 'not going back in time' after settlement, CNBC says » 16:58
09/25/20
09/25
16:58
09/25/20
16:58
GOOG

Alphabet

$1,444.74 /

+18.02 (+1.26%)

, GOOGL

Alphabet Class A

$1,440.67 /

+19.2 (+1.35%)

Alphabet and Google CEO…

Alphabet and Google CEO Sundar Pichai sent out a memo to employees highlighting a new settlement between the company and shareholders who claimed it did not respond appropriately to allegations of sexual misconduct and harassment, CNBC's Jennifer Elias reports. "I hope these commitments will serve as a strong signal to all of you that we are not going back in time," Pichai told employees in an memo viewed by CNBC. "It's very important to me that we hold ourselves to the highest possible standard as a workplace on issues of misconduct, and provide care and support to people who report it," Pichai added. "I've been working closely with our teams and our board to ensure that we are doing this." Reference Link

ShowHide Related Items >><<
GOOGL Alphabet Class A
$1,440.67 /

+19.2 (+1.35%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/25/20 UBS
Alphabet price target raised to $1,970 from $1,600 at UBS
GOOGL Alphabet Class A
$1,440.67 /

+19.2 (+1.35%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

GOOG Alphabet
$1,444.74 /

+18.02 (+1.26%)

GOOGL Alphabet Class A
$1,440.67 /

+19.2 (+1.35%)

GOOGL Alphabet Class A
$1,440.67 /

+19.2 (+1.35%)

Syndicate
Can-Fite BioPharma files $100M mixed securities shelf  16:39
09/25/20
09/25
16:39
09/25/20
16:39
CANF

Can-Fite BioPharma

$1.73 /

+0.01 (+0.58%)

 
ShowHide Related Items >><<
CANF Can-Fite BioPharma
$1.73 /

+0.01 (+0.58%)

CANF Can-Fite BioPharma
$1.73 /

+0.01 (+0.58%)

10/31/19 H.C. Wainwright
Can-Fite BioPharma price target raised to $5 from $3 at H.C. Wainwright
Syndicate
Torchlight Energy files $60M mixed securities shelf  16:37
09/25/20
09/25
16:37
09/25/20
16:37
TRCH

Torchlight Energy Resources

$0.24 /

+0.0066 (+2.87%)

 
ShowHide Related Items >><<
TRCH Torchlight Energy Resources
$0.24 /

+0.0066 (+2.87%)

TRCH Torchlight Energy Resources
$0.24 /

+0.0066 (+2.87%)

03/13/20 Roth Capital
Torchlight Energy Resources downgraded to Neutral from Buy at Roth Capital
03/03/20
LD Micro to hold a virtual conference
  • 14
    Jan
Conference/Events
Morgan Stanley retail real estate analysts hold analyst/industry conference call » 16:36
09/25/20
09/25
16:36
09/25/20
16:36

Retail Real Estate…

Retail Real Estate Analysts discuss the future of the industry with Time Equities on an Analyst/Industry conference call to be held on October 2 at 11 am.

Syndicate
A-Mark Precious Metals files $150M mixed securities shelf  16:31
09/25/20
09/25
16:31
09/25/20
16:31
AMRK

A-Mark Precious Metals

$32.23 /

+0.5 (+1.58%)

 
ShowHide Related Items >><<
AMRK A-Mark Precious Metals
$32.23 /

+0.5 (+1.58%)

AMRK A-Mark Precious Metals
$32.23 /

+0.5 (+1.58%)

08/24/20
Fly Intel: Top five analyst initiations
08/24/20 Roth Capital
A-Mark Precious Metals initiated with a Buy at Roth Capital
AMRK A-Mark Precious Metals
$32.23 /

+0.5 (+1.58%)

AMRK A-Mark Precious Metals
$32.23 /

+0.5 (+1.58%)

Conference/Events
Kennedy Wilson participates in a conference call with Deutsche Bank » 16:30
09/25/20
09/25
16:30
09/25/20
16:30
KW

Kennedy Wilson

$14.56 /

+0.23 (+1.61%)

Conference call with…

Conference call with management will be held on September 29 hosted by Deutsche Bank.

ShowHide Related Items >><<
KW Kennedy Wilson
$14.56 /

+0.23 (+1.61%)

KW Kennedy Wilson
$14.56 /

+0.23 (+1.61%)

09/08/20 Deutsche Bank
Kennedy Wilson upgraded to Buy from Hold at Deutsche Bank
01/27/20 BofA
Kennedy Wilson initiated with a Neutral at BofA
KW Kennedy Wilson
$14.56 /

+0.23 (+1.61%)

General news
Treasury Market Summary » 16:30
09/25/20
09/25
16:30
09/25/20
16:30

Treasury Market Summary:…

Treasury Market Summary: Wall Street continued its choppy ways as the week came to an end. The market got off to a rocky start after stumbling in European action where rising virus cases and resumption of containment measures left a more bearish tone. And a disappointing headline on durable goods orders sparked selling pressures as it played into worries that the recovery is losing steam. The lack of additional fiscal stimulus is adding to the frustrations. However, dip buyers stepped in to boost the major indexes and momentum accelerated into the close. Tech again led the way with the NASDAQ surging 2.26%, but gains were broadbased with the S&amp;P 500 and Dow over 1.3% firmer. The NASDAQ managed a 1.1% rally on the week, though the broader indexes closed in the red again for the worst stretch in a year. Treasuries caught an early safety bid due to the growing angst, with yields fall slid to multi-week lows after the data. But rates closed off their nadirs as stocks rebounded. The only data was durable goods where the guts of the report were much better than the headline. View the summary.

Options
Preliminary option volume of 27.1M today » 16:30
09/25/20
09/25
16:30
09/25/20
16:30

Preliminary option volume…

Preliminary option volume of 27.1M today is 16% below recent average. Calls led puts 15.44M to 11.69M.

Periodicals
About 3,500 U.S. companies sue White House over Chinese tariffs, Reuters says » 16:29
09/25/20
09/25
16:29
09/25/20
16:29
SPY

SPDR S&P 500 ETF Trust

$328.69 /

+5.19 (+1.60%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

, HD

Home Depot

$268.69 /

+2.98 (+1.12%)

, WBA

Walgreens Boots Alliance

$35.43 /

+0.4 (+1.14%)

, TGT

Target

$154.40 /

+2.41 (+1.59%)

, F

Ford

$6.51 /

-0.145 (-2.18%)

, TSLA

Tesla

$407.32 /

+19.67 (+5.07%)

Roughly 3,500 U.S.…

Roughly 3,500 U.S. companies, including Tesla (TSLA), Ford (F), Target (TGT), Walgreen Co. (WBA), and Home Depot (HD), have sued the Trump administration in recent weeks over the imposition of tariffs on over $300B in Chinese-made goods, Reuters' David Shepardson reports. The suits, which were filed in the U.S. Court of International Trade, named U.S. Trade Representative Robert Lighthizer and the Customs and Border Protection agency and challenge what the companies perceive as the unlawful escalation of the U.S. trade war with China through the placement of a third and fourth round of duties, Shepardson says. The legal challenges from a broad variety of companies claim that the White House failed to impose tariffs within a required 12-month period and did not comply with administrative procedures, the author says. Reference Link

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$35.43 /

+0.4 (+1.14%)

TSLA Tesla
$407.32 /

+19.67 (+5.07%)

TGT Target
$154.40 /

+2.41 (+1.59%)

SPY SPDR S&P 500 ETF Trust
$328.69 /

+5.19 (+1.60%)

HD Home Depot
$268.69 /

+2.98 (+1.12%)

F Ford
$6.51 /

-0.145 (-2.18%)

SPY SPDR S&P 500 ETF Trust
$328.69 /

+5.19 (+1.60%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

HD Home Depot
$268.69 /

+2.98 (+1.12%)

09/18/20
Fly Intel: Top five analyst downgrades
09/18/20 Oppenheimer
Oppenheimer downgrades Home Depot, Lowe's on near-term risks
09/18/20 Oppenheimer
Home Depot downgraded to Perform from Outperform at Oppenheimer
08/26/20 Jefferies
Lowe's price target raised to $205 from $193 at Jefferies
WBA Walgreens Boots Alliance
$35.43 /

+0.4 (+1.14%)

09/11/20 Mizuho
Walgreens Boots Alliance price target lowered to $37 from $43 at Mizuho
09/02/20 RBC Capital
Walgreens Boots Alliance price target lowered to $38 from $45 at RBC Capital
09/01/20 Deutsche Bank
Walgreens CEO hire 'bit of a step backward,' says Deutsche Bank
07/28/20 Baird
Walgreens Boots Alliance CEO change to bring fresh perspective, says Baird
TGT Target
$154.40 /

+2.41 (+1.59%)

09/22/20 Cleveland Research
Target sales appear to be re-accelerating, says Cleveland Research
08/20/20 MKM Partners
Target facing 'likely deceleration' from August levels, says MKM Partners
08/20/20 JPMorgan
Target price target raised to $169 from $154 at JPMorgan
08/20/20 DA Davidson
Target price target raised to $179 from $152 at DA Davidson
F Ford
$6.51 /

-0.145 (-2.18%)

09/18/20 Stifel
Fox Factory upgraded to Buy following pullback at Stifel
09/08/20
Fly Intel: Top five analyst upgrades
09/08/20 Evercore ISI
Evercore ISI giving Ford 'benefit of the doubt,' upgrades to In Line
09/08/20 Evercore ISI
Ford upgraded to In Line from Underperform at Evercore ISI
TSLA Tesla
$407.32 /

+19.67 (+5.07%)

09/24/20 Roth Capital
Tesla's Battery Day event 'disappoints,' says Roth Capital
09/24/20 Daiwa
Daiwa upgrades Rockwell Automation after customer Tesla's Battery Day
09/24/20 Wedbush
Wedbush downgrades Nikola to sell on 'dark cloud,' Tesla innovations
09/23/20
Fly Intel: Top five analyst upgrades
WBA Walgreens Boots Alliance
$35.43 /

+0.4 (+1.14%)

TSLA Tesla
$407.32 /

+19.67 (+5.07%)

TGT Target
$154.40 /

+2.41 (+1.59%)

SPY SPDR S&P 500 ETF Trust
$328.69 /

+5.19 (+1.60%)

HD Home Depot
$268.69 /

+2.98 (+1.12%)

F Ford
$6.51 /

-0.145 (-2.18%)

  • 14
    Feb
WBA Walgreens Boots Alliance
$35.43 /

+0.4 (+1.14%)

TSLA Tesla
$407.32 /

+19.67 (+5.07%)

TGT Target
$154.40 /

+2.41 (+1.59%)

SPY SPDR S&P 500 ETF Trust
$328.69 /

+5.19 (+1.60%)

HD Home Depot
$268.69 /

+2.98 (+1.12%)

F Ford
$6.51 /

-0.145 (-2.18%)

WBA Walgreens Boots Alliance
$35.43 /

+0.4 (+1.14%)

TSLA Tesla
$407.32 /

+19.67 (+5.07%)

TGT Target
$154.40 /

+2.41 (+1.59%)

HD Home Depot
$268.69 /

+2.98 (+1.12%)

F Ford
$6.51 /

-0.145 (-2.18%)

WBA Walgreens Boots Alliance
$35.43 /

+0.4 (+1.14%)

TSLA Tesla
$407.32 /

+19.67 (+5.07%)

TGT Target
$154.40 /

+2.41 (+1.59%)

SPY SPDR S&P 500 ETF Trust
$328.69 /

+5.19 (+1.60%)

SPX S&P 500
$0.00 /

+ (+0.00%)

HD Home Depot
$268.69 /

+2.98 (+1.12%)

F Ford
$6.51 /

-0.145 (-2.18%)

SPY SPDR S&P 500 ETF Trust
$328.69 /

+5.19 (+1.60%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.